Impact of Proposed Budget on Health Research: Hearing Before a Subcommittee of the Committee on Appropriations, United States Senate, Ninety-ninth Congress, Second Session : Special Hearing, Nondepartmental WitnessesU.S. Government Printing Office, 1986 - 66 pages |
From inside the book
Results 1-5 of 10
Page 3
... reasonably have been reduced because the NIH investment has failed to pay adequate dividends - the prevention of polio and hepatitis , the reduction of infant mortality , improvement in cancer survival , and reductions in deaths from ...
... reasonably have been reduced because the NIH investment has failed to pay adequate dividends - the prevention of polio and hepatitis , the reduction of infant mortality , improvement in cancer survival , and reductions in deaths from ...
Page 7
... REASONABLY HAVE BEEN REDUCED BECAUSE THE NIH INVEST- MENT HAS FAILED TO PAY ADEQUATE DIVIDENDS -- PREVENTION OF POLIO AND HEPATITIS , REDUCTION OF INFANT MORTALITY , IMPROVEMENT IN CANCER SURVIVAL . AND REDUCTION IN DEATHS FROM CORONARY ...
... REASONABLY HAVE BEEN REDUCED BECAUSE THE NIH INVEST- MENT HAS FAILED TO PAY ADEQUATE DIVIDENDS -- PREVENTION OF POLIO AND HEPATITIS , REDUCTION OF INFANT MORTALITY , IMPROVEMENT IN CANCER SURVIVAL . AND REDUCTION IN DEATHS FROM CORONARY ...
Page 19
... reasonable cost through the efforts of pharmaceutical industry . The message that I want to bring here is very simple . All basic research in modern medicine and the related biology in the United States and all the advances in medicine ...
... reasonable cost through the efforts of pharmaceutical industry . The message that I want to bring here is very simple . All basic research in modern medicine and the related biology in the United States and all the advances in medicine ...
Page 24
... REASONABLE RATE OF RETURN TO DRUG MANUFACTURERS . I WOULD ALSO ADD THAT WE HAVE SEEN GREAT PROGRESS IN DEVELOPING DRUGS FOR RARE DISEASES . THESE SO- CALLED " ORPHAN DRUGS " ARE ANOTHER EXPRESSION OF THE INTERACTIVE STRENGTH IN OUR ...
... REASONABLE RATE OF RETURN TO DRUG MANUFACTURERS . I WOULD ALSO ADD THAT WE HAVE SEEN GREAT PROGRESS IN DEVELOPING DRUGS FOR RARE DISEASES . THESE SO- CALLED " ORPHAN DRUGS " ARE ANOTHER EXPRESSION OF THE INTERACTIVE STRENGTH IN OUR ...
Page 25
... REASONABLE AMOUNT OF GROWTH IN THE NATIONAL BIOMEDICAL RESEARCH EFFORT , PARTICULARLY THROUGH NEW PROGRAMS OF THE NATIONAL INSTITUTES OF HEALTH . OPPORTUNITIES LOST ARE NOT EASILY REGAINED . DISCONTINUED OR INTERRUPTED PROGRAMS ARE NOT ...
... REASONABLE AMOUNT OF GROWTH IN THE NATIONAL BIOMEDICAL RESEARCH EFFORT , PARTICULARLY THROUGH NEW PROGRAMS OF THE NATIONAL INSTITUTES OF HEALTH . OPPORTUNITIES LOST ARE NOT EASILY REGAINED . DISCONTINUED OR INTERRUPTED PROGRAMS ARE NOT ...
Other editions - View all
Common terms and phrases
ADAMHA administration alcoholism Alzheimer's disease American Heart Association awards baby boomers basic biomedical research basic research biomedical research Blood Institute brain cardiovascular disease Chairman cholesterol cholesterol research clinical trials commitment competing grants concerned CONGRESS LIBRARY CONGRESS THE LIBRARY coronary heart disease Director dollars drug equipment Federal funding GEORGE PALADE geriatrics going Gramm-Rudman GUILLEMIN impact important increase individual institutes Institute on Aging Institutes of Health investment laboratories leadership LIBRARY OF CONGRESS medical research medicine mental illness million National Cancer Institute National Institutes NHLBI NIH budget NIMH number of grants number of research opportunities PALADE Pardes percent polio present President President's budget problem proposed budget recommended reduce research centers research effort research grants research projects research training ROGER GUILLEMIN Salk Institute scientific scientists Senator HATFIELD Senator WEICKER stability STATEMENT OF DR subcommittee Thank THEODORE COOPER Thier young
Popular passages
Page 38 - Identified and studied the consequences of drug use, including the effects of drugs on fetal development, motivation and emotion, personality and cognitive abilities, and performance, as well as the consequences of cessation of chronic drug use. Identified the precise, sub-cellular biochemical changes in the nervous systems of animals during - 4 learning ana the formation of memory.
Page 64 - Service, which includes the Alcohol, Drug Abuse and Mental Health Administration; the Centers for Disease Control; the Food and Drug Administration; the Health Resources and Services Administration; and the National Institutes of Health.
Page 13 - Brookdale Professor of Geriatrics and Adult Development and Chairman of the Gerald and May Ellen Hitter Department of Geriatrics and Adult Development at Mount Sinai School of Medicine...
Page 6 - He is a member of the Institute of Medicine of the National Academy of Sciences and...
Page 35 - States, is under the supervision of Dr. Nolan DC Lewis, Executive Officer of the Department of Psychiatry at Columbia University and Director of the New York State Psychiatric Institute and Hospital. Dr. George E. Daniels, Clinical Professor of Psychiatry, has been appointed Chief of the Psychosomatic Service.
Page 49 - Its mission — the reduction of premature death and disability from heart disease, stroke and related disorders. In accomplishing this goal we work closely with Federal research, education and prevention programs, whose goals are similar in nature. Since 1948. the AHA and the National Heart. Lung and Blood Institute (NHLBI) have been active partners in the battle against cardiovascular disease, this nation's leading cause of death. We...
Page 2 - NIH to become president of the Institute of Medicine (IOM) of the National Academy of Sciences.
Page 36 - He appreciate the Subcommittee questions to the Administration witnesses which for the first time made public that there exists a potentially critical budget shortfall in the NIMH Research Centers mechanism in which funding for six competing/renewal centers is eliminated. The typical MHCKC grant provides...
Page 50 - ... underlie normal cardiac morphogenisis in order to increase understanding of the etiology and pathogenisis of congenital heart failures. • a clinical trial to assess behavioral and lifestyle interventions contributing to an individual's successful adjustment after coronary artery bypass graft (CABG) surgery and to identify operative, clinical and other factors that may predict early and late graft narrowing and occlusion after surgery. • an investigation into the feasiblity, acceptability,...
Page 40 - FY 1986) Allow NIDA to add 16 new and competing grants above the FY 1986 level of 100 awarded, including the funding for 3 major grants to support large clinical and treatment research projects! Enhance dramatically...